Rhabdomyolysis Associated with Intravenous Zoledronic Acid Infusion for the Treatment of Postmenopausal Osteoporosis.

被引：0
|
作者：
Schaefer, M. W. [1 ]
Gopalakrishnan, G. [1 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment with etidronate or alendronate in postmenopausal osteoporosis.
    Lissens, MA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S277 - S277
  • [22] Rationale for intermittent intravenous Ibandronate injections in postmenopausal osteoporosis.
    Miller, PD
    Recker, RR
    Adami, S
    Bonvoisin, B
    Schimmer, RC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S263 - S263
  • [23] ZOLEDRONIC ACID UTILIZATION AND FACTORS ASSOCIATED WITH RECEIPT OF FOLLOW-UP INFUSION: A SURVEY OF PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    Gold, D. T.
    Cheng, L.
    Chastek, B. J.
    White, J. C.
    Silverman, S. L.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S265 - S266
  • [24] Vitamin D Reduces Musculoskeletal Pain After Infusion of Zoledronic Acid for Postmenopausal Osteoporosis
    Catalano, Antonino
    Morabito, Nancy
    Atteritano, Marco
    Basile, Giorgio
    Cucinotta, Domenico
    Lasco, Antonino
    CALCIFIED TISSUE INTERNATIONAL, 2012, 90 (04) : 279 - 285
  • [25] Vitamin D Reduces Musculoskeletal Pain After Infusion of Zoledronic Acid for Postmenopausal Osteoporosis
    Antonino Catalano
    Nancy Morabito
    Marco Atteritano
    Giorgio Basile
    Domenico Cucinotta
    Antonino Lasco
    Calcified Tissue International, 2012, 90 : 279 - 285
  • [26] HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis
    不详
    FORMULARY, 2007, 42 (08) : 488 - 489
  • [27] Effectiveness of intravenous pamidronate in the treatment of osteoporosis.
    Cohen, H
    Rhys-Dillon, C
    Evans, WD
    Martin, JC
    Morgan, J
    Rajan, KT
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
  • [28] Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
    Patricia Sieber
    Patrizia Lardelli
    Claude A. Kraenzlin
    Marius E. Kraenzlin
    Christian Meier
    Clinical Drug Investigation, 2013, 33 : 117 - 122
  • [29] Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
    Sieber, Patricia
    Lardelli, Patrizia
    Kraenzlin, Claude A.
    Kraenzlin, Marius E.
    Meier, Christian
    CLINICAL DRUG INVESTIGATION, 2013, 33 (02) : 117 - 122
  • [30] A Clinician's Perspective on the Use of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis
    Lewiecki, E. Michael
    JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (04) : 478 - 484
12345